Xiang Wang

Successful Treatment of TCF3-HLF-positive Childhood B-ALL with Chimeric Antigen Receptor T-Cell Therapy.

Lixia Ding, Tianyi Wang, Xinyu Wan, 2021, Clinical lymphoma, myeloma & leukemia.

Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse

Lixia Ding, Lili Song, J. Chen, 2021, Cancer research and treatment.

Mutations in methionyl-tRNA synthetase gene in a Chinese family with interstitial lung and liver disease, postnatal growth failure and anemia

Jing Chen, Yongguo Yu, Guorui Hu, 2017, Journal of Human Genetics.

Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification

S. Shen, Yu Liu, J. Chen, 2020, Nature Communications.

Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial

Cheng Cheng, C. Pui, Lixia Ding, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Modeling leukemia with pediatric acute leukemia patient-derived iPSCs.

Yang Li, Ting Li, Yi Yang, 2021, Stem cell research.

Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy

Lixia Ding, Lili Song, Xiang Wang, 2023, Journal of Translational Medicine.

Long‐term results of the risk‐stratified treatment of childhood acute lymphoblastic leukemia in China

Yi-Jin Gao, S. Shen, Jingyan Tang, 2018, Hematological oncology.

Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia

Lixia Ding, Ben-shang Li, Huiying Sun, 2023, Nature communications.